The global stem cell therapy market size is expected to grow from $10.67 billion in 2021 to $11.99 billion in 2022 at a compound annual growth rate (CAGR) of 12.4%. The growth in the market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The stem cell therapy market is expected to reach $21.17 billion in 2026 at a CAGR of 15.3%.
What is the Global Stem Cell Therapy Market?
The stem cell therapy market consists of the sales of stem cell therapy and related services by entities (organizations, sole traders, and partnerships) that provide stem cell therapy. Stem cell therapy, also known as regenerative medicine, promotes the repair response of diseased patient, dysfunctional or injured tissue using stem cells or their derivatives. Only goods and services traded between entities or sold to end consumers are included.
Get a Sample of the global stem cell therapy market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3399&&type=smp
What drives the Global Stem Cell Therapy Market?
The rising prevalence of chronic diseases contributed to the growth of the stem cell therapy market. Long working hours, limited physical activity, and unhealthy eating and drinking habits contribute to the prevalence of chronic diseases among people, thus driving the need for stem cell therapy. According to a United Nations article, by 2030, the proportion of global deaths due to chronic diseases is expected to increase to 70% of total deaths. The global burden of chronic diseases is expected to reach about 60%. The rising prevalence of chronic diseases is expected to drive the stem cell therapy market.
Get the full global stem cell therapy industry report here
https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report
Global Stem Cell Therapy Market Segments
The global stem cell therapy market is segmented:
By Type: Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy
By Cell Source: Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells
By Application: Musculoskeletal Disorders, Wounds and Injuries, Cancer, Autoimmune Disorders, Others
By End-User: Hospitals, Clinics
By Geography: The regions covered in the stem cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Stem Cell Therapy Global Market Report 2022provides market size and growth forecasts for the global stem cell therapy market, global stem cell therapy market share, stem cell therapy market segments and geographies, stem cell therapy market competitive landscape including leading competitors’ revenues, profiles and market shares. The stem cell therapy market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Global Stem Cell Therapy Industry Playersinclude Anterogen, JCR Pharmaceuticals, Medipost, Osiris Therapeutics, Pharmicell, Astellas Pharma, Cellectis, Celyad, Novadip Biosciences, Gamida Cell, Capricor Therapeutics, Cellular Dynamics, CESCA Therapeutics, DiscGenics, OxStem, Mesoblast, ReNeuron Group, Takeda Pharmaceuticals, Magellan, Kolon TissueGene, Stemedica Cell Technologies, Holostem Terapie Avanzate S.r.l., NuVasive, RTI Surgical and AlloSource. Based on industry trends and company analysis, the report explains a number of strategies for companies in the market.
